DexCom Shares (Diluted) decreased by 3.4% to 393.6M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.4%, from 407.5M to 393.6M. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates potential dilution from employee compensation or convertible instruments, which can reduce earnings per share.
The weighted-average number of common shares outstanding plus the effect of all potentially dilutive securities, such as...
Standard metric for all public companies; essential for understanding the impact of equity-based compensation.
weighted_shares_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 427.1M | 430.3M | 900K | 428.7M | 421.4M | 425.8M | 418.5M | 431.5M | 426.8M | 416.7M | 416.8M | 410.2M | 407.5M | 408.2M | 407.4M | 393.6M |
| QoQ Change | — | +0.7% | -99.8% | >999% | -1.7% | +1.0% | -1.7% | +3.1% | -1.1% | -2.4% | +0.0% | -1.6% | -0.7% | +0.2% | -0.2% | -3.4% |
| YoY Change | — | — | — | — | -1.3% | -1.0% | -2.4% | +2.4% | +0.2% | -0.4% | -3.4% | -3.9% | -2.2% | -2.1% | -0.7% | -3.4% |